国产高清不产二区三区|综合日韩天天久久一本|欧美日韩国产综合新一区|日韩一区二区午夜福利视频|日韩国产成人无码av毛片|亚洲欧美中文日韩二区一区|国产全黄三级国产全黄三级书|18pao国产成视频永久免费

In 2017, the company plans to achieve an annual sales revenue of 160 million yuan and a profit of 25 million yuan. By 2020, the output value will exceed 50 million yuan and the profit and tax income will reach 80 million yuan. The company makes the greatest contribution to revitalizing the local economy to increase fiscal revenue.

On June 10, 2015, the company was successfully listed on the New Third Board, which laid a solid foundation for the company's next great and rapid development.

In 2014, the company invested 40 million yuan to build the Jiangxi Rainbow Pharmaceutical medical raw material research, production and sale project(The first phase of the project has entered the installation and commissioning phase), to expand the scale of production and expand new fields.

In 2014, the company successfully completed the joint-stock transformation and registered and established Anhui Jinquan Biotechnology Co. Ltd.

In 2012, the company was also recognized by the provincial government as "Provincial Enterprise Technology Center", the company has been awarded "Anhui Private Technology Enterprise", "Anqing Financial trustworthy Enterprise", "Anqing Import and Export advanced Enterprise", "Anqing Wangjiang County Industrial Top Ten Enterprises" and other honors, the company chairman Mr. He Guangquan has been awarded "Excellent entrepreneur" and other titles for many times.

In 2011, the company was identified by the Anqing Municipal People's Government as the "Municipal Enterprise Technology Center", the company was awarded the "Anqing Outstanding Innovative Enterprise".

In 2005, Anhui Jinquan Biotechnology Co., Ltd. (formerly Anqing Jinquan Pharmaceutical Co., Ltd.) was founded in 2005. The company is located in Leichi Industrial Zone in Wangjiang County. The company covers an area of over 80mu with a construction area of 22,000 square meters. The company is a private technological enterprise specializing in production, research and sales.